Matthew Gubin, PhD, postdoctoral research scholar in the laboratory of Robert Schreiber, PhD, Alumni Professor of Pathology and Immunology at Washington University School of Medicine in St. Louis, has received a three-year, $164,500 grant from the Cancer Research Institute for research titled “Using Genomics to Identify Targets of Checkpoint Blockade Cancer Treatment and Identify Optimal Target Antigens for Vaccination.”
Latest from the Record
Announcements
Information security policies updated
Notables
Eberlein named president-elect of American College of Surgeons
Obituaries
J. Claude Evans, philosopher, 79
James Ballard, former director of Engineering Communication Center, 79
Obituary: Stuart A. Kornfeld, professor emeritus of medicine, 88